Number of items: 2
|Field, KM and Simes, J and Nowak, AK and Cher, L and Wheeler, H and Hovey, EJ and Brown, CSB and Barnes, EH and Sawkins, K and Livingstone, A and Freilich, R and Phal, PM and Fitt, G and Rosenthal, MA and Arzhintar, I and Garrett, L and Byrne, A and Dowling, A and Ranieri, N and Jennens, R and Osmond, F and Patterson, WK and Phay, A and Abell, F and Plowman, L and Flynn, J and Hovey, E and Kilsby, H and Wheeler, H and Kirby-Lewis, S and Singhal, N and Smith, S and Whelan, M and Inglis, P and Ives, A and Nowak, A and Lobb, S and Begbie, S and Williams, P and Lwin, Z and Woodward, N and Crosbie, G and Harrup, R and Pyszkowski, L and Gauden, S and Neville, A, Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma, Neuro-Oncology, 17, (11) pp. 1504-1513. ISSN 1522-8517 (2015) [Refereed Article]|
|Gauden, R and Gauden, S, Optimal duration of imatinib mesylate therapy in metastatic gastrointestinal stromal tumours, Case Reports in Oncology, 4, (1) pp. 204-210. ISSN 1662-6575 (2011) [Refereed Article]|
This list was generated on Fri Oct 7 19:25:25 2022.